bleeding at the radial arterial line site every 6 h after the start of CPS. The day that the minimum platelet count occurred during CPS was investigated. The serum CK-MB concentration was measured both on the day that CPS was started and the day of cessation. The 2-dimensional echocardiographic evaluation included determination of the LVEF and the left ventricular diastolic diameter normalized to the age-matched diameter (LVDd%N) 1 h before and after discontinuing CPS. The presence of pericardial effusion and left ventricular dyskinesis was determined when the patient was connected to CPS and 1 h before weaning. The SvO2 was measured at the time CPS was initiated and within 1 h before weaning.
Informed consent for CPS was obtained from the patients' legal guardians, and the protocol was approved by the Ethical Committee on Clinical Investigation, Nihon University School of Medicine on March 25, 1999.
Results
All 4 patients underwent CPS safely without complications, including fatal thromboembolism or disseminated intravascular coagulation, but also without the need to exchange the circuit during the procedure. The results of CPS are summarized in Table 2 . Three patients underwent open chest CPS, and a 13-year-old boy underwent percutaneous CPS. The average time required to establish CPS from the onset of symptoms was 17.6 h (range: 6.0-37.5). The longest duration of CPS was in patient 3, because cardiac function had been maintained with medications until 37.5 h after arrival. The mean maximum pump flow rate was 1.59 L·min -1 ·m -2 (range: 1.20-1.80). The mean duration was 53.1 h (range: 33.5-77.0) and the longest duration was 77.0 h in the 13-year-old boy, who did not develop leg ischemia. Table 3 shows laboratory data and a summary of the bleeding episodes. The minimum platelet count occurred on the day of weaning in all 4 patients with a mean platelet count of 91×10 3 . Three patients had bleeding at the radial arterial line site, but the patient with the shortest duration of CPS had no bleeding. The average duration was 50 h (range: 42-60) from CPS initiation to the bleeding episode. The peak serum CK-MB concentration was 117.0 IU/L (range: 62.0-169.0) on the day of starting CPS, and 51.5 IU/L (range: 7.0-114.0) on the day of ceasing CPS. Echocardiographic data are summarized in Table 4 . The LVEF did not change between the time before CPS and after stopping CPS. The LVDd%N after stopping CPS was greater than before stopping. Pericardial effusion and left ventricular dyskinesis were present when initiating CPS in all 4 patients. These findings reflect the deterioration in cardiac function without CPS support and they resolved before weaning off CPS in all 4 patients. Table 5 includes data for SvO2, which was higher just before weaning compared with the value at the time of starting CPS in all 4 patients. A decrease in the SvO2 after weaning did not occur.
All 4 patients underwent cardiac catheterization, which revealed normal electrophysiologic findings and a normal cardiac index. All 4 patients survived without any longterm complications.
Discussion
Based on the recommendations of the National Survey of Fulminant Myocarditis in Japan, 8 the criteria for weaning off CPS in adults with fulminant myocarditis include: (1) SvO2 >60%, (2) improved left ventricular wall motion, and (3) improved LVEF. In contrast, there are no criteria for weaning off CPS in children with fulminant myocarditis. Weaning may be scheduled based on the duration of CPS, even if the cardiac function has not normalized. Once serious complications develop, such as thromboembolism or disseminated intravascular coagulation, the prognosis is very poor. We used a heparin-coated circulating system and performed CPS without exchanging the circuit in all 4 pediatric patients to prevent these complications.
Percutaneous CPS may also be associated with other complications, including leg ischemia. We positioned the arterial catheter in the common femoral artery with a side branch providing flow into the 18-gauge catheter down the superficial femoral artery, as previously reported, 9 to prevent leg ischemia. Methods for dealing with leg ischemia have been reported in adult patients. 10 In the present study the mean duration of CPS was 53.1 h, but was longer in case of percutaneous CPS compared with open-chest CPS cases. In contrast, in a previous report describing a 14-year-old girl with fulminant myocarditis the duration of CPS was 7 days. 11 In all 4 of the present patients the minimum platelet count during CPS occurred on the day of CPS weaning. It is important to note that weaning should be completed in as short a time as possible, especially if any complications, such as thromboembolism, disseminated intravascular coagulation or leg ischemia, develop. We found that bleeding occurred at the radial arterial line site 50 h after starting CPS.
Based on the findings from the present study we propose that the appropriate duration of CPS could be 3 days or less for the following reasons. First, the initial bleeding episode was observed on day 3 (mean: 50 h) after the start of CPS. Second, the minimum platelet count occurred on the day of weaning, which was also day 3.
The serum CK-MB concentration may be helpful in making the decision to wean CPS. In the present patients the peak value of the serum CK-MB on the day of weaning was lower than on the day of starting CPS. The National Survey of Fulminant Myocarditis in Japan demonstrated that the peak of CK-MB before CPS starting and the maximum CK-MB during CPS in patients who could be weaned were lower compared with patients who could not be weaned (before: 134±262 vs 250±118; during: 129±159 vs 302±239). 8 Those results indicate that patients could be weaned if the CK-MB value peaked during CPS. The serum CK-MB concentration may be a diagnostic biomarker for CPS weaning. The serum troponin T increases in patients with myocarditis, 12 and is unique to cardiac tissue. There may be a good relationship between well-timed CPS weaning and the level of indicators of myocardial cell damage such as CK-MB or troponin T.
In the present study the LVEF after weaning was similar to that before weaning, and the LVDd%N after stopping CPS was greater than that before weaning. We believe that the echocardiographic findings during CPS reflect not only the cardiac function itself but also the degree of supportive flow from the CPS. Nakagawa and Hamaoka reported that transient ventricular wall thickening appeared to be unrelated to the degree of cardiac function in children with acute myocarditis, 13 and is caused by interstitial edema in patients with acute myocarditis. 14 We observed that transient intraventricular septal wall and left ventricular posterior wall thickening, with a mildly increased LVDd, occurred between 2 and 4 weeks after weaning off CPS in 4 patients without cardiac dysfunction. Factors such as the LVEF and LVDd%N may be used for evaluating the timing of weaning; however, in our study patients the presence of pericardial effusion or left ventricular dyskinesis did not mitigate the findings of an improved LVEF or LVDd%N. We believe that weaning off CPS could be postponed if there is pericardial effusion or left ventricular dyskinesis, because these abnormalities directly influence cardiac function without affecting the supportive flow from CPS. The SvO2 was >65% just before weaning in all 4 patients, which satisfied the adult criteria of the National Survey in Japan 8 for CPS weaning. We believe that similar recommendations for the SvO2 in children are useful. The SvO2 may be more reliable than arterial blood pressure as a recommendation for cessation, because arterial blood pressure can be controlled using inotropic agents.
The small number of patients is a limitation of the present study in determining the recommendations for weaning. Our recommendations for weaning children with fulminant myocarditis from CPS are summarized in Table 6 : (1) Weaning can be completed before bleeding episodes are detected, (2) weaning can be completed after pericardial effusion and left ventricular dyskinesis are resolved, (3) the SvO2 should be >60% just before cessation, (4) weaning can be performed after the CK-MB value reaches its peak, (5) exchange of the circuit can not be performed, and (6) the duration of CPS can be 3 days or less. The most important factors are (1) and (2), because those conditions are related to the clinical background of the patient. We believe that recommendation (3) is appropriate, based on the criteria established for adults. 8 Recommendation (4) is a relative indication and we think that recommendations (5) and (6) may be helpful for completing weaning in children based on the following 2 reasons. First, these recommendations are for children who are predisposed to thromboembolism and may have had complicated cannulation. Second, fulminant myocarditis is serious, but can be transient with a short duration, especially in children. In our hospital we suggest weaning after achieving recommendations (1) to (5) in children with fulminant myocarditis.
